MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical predictors of screen-defined dementia in early Parkinson’s

F. Baig, M. Lawton, M. Rolinski, C. Ruffmann, T. Barber, J. Klein, C. Lo, Y. Ben-Shlomo, M. Hu (Oxford, United Kingdom)

Meeting: 2018 International Congress

Abstract Number: 1256

Keywords: Parkinsonism dementia complex(PDC)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Cognition

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: Predicting early dementia in Parkinson’s disease (PD) has important implications for individual prognosis, designing clinical trials and targeting novel treatments, but there remains a lack of evidence in this area.

Background: This study examined which clinical factors predicted early dementia in a large cohort of early PD subjects.

Methods: Parkinson’s patients assessed within 3.5 years of diagnosis were recruited between 2010-2015 (the Discovery cohort, UK) and then re-assessed after 18 months. The Montreal cognitive assessment was used to assess cognition, using a score of <23 for screen-defined dementia. A broad spectrum of other motor and non-motor symptoms were also assessed. A logistic regression model with backwards stepwise selection was used to determine which baseline clinical assessments were independent predictors of dementia at 18 months.

Results: 61 of the 488 included PD patients developed new dementia at 18 month follow-up. Older age at diagnosis (OR 1.65 (95% CI 1.26-2.17), p<0.001) with poor performance on phonemic fluency (OR 4.03 (95% CI 1.87-8.70), p<0.001), cube copying (OR 1.94 (95% CI 1.31-2.86), p=0.001), and the Purdue assembly test (3.66 (95% CI 1.86-7.21), p<0.001) were all included in the final model as independent predictors of dementia (see figure 1). Figure 1 - Odds ratios of model for factors predicting dementia, with their 95% confidence intervals. Age at diagnosis was analysed as a 5 level ordinal variable, cube copying errors was analysed as a 3 level ordinal variable, and both phonemic fluency and purdue assembly were analysed as a dichotomous variables (poor performers <20th gentile). The area under the ROC curve for this model is estimated at 0.81 (95% CI 0.74-0.89) (see figure 2). Figure 2 - ROC curve depicting model of factors predicting dementia including age at diagnosis, Purdue assembly task, phonemic fluency and cube copying connection errors.

Conclusions: Poor performance on three simple clinical tests performed early in PD (the Purdue assembly task, phonemic fluency and cube copying) can be used to predict early dementia. This has implications for both clinical practice and clinical trials.

To cite this abstract in AMA style:

F. Baig, M. Lawton, M. Rolinski, C. Ruffmann, T. Barber, J. Klein, C. Lo, Y. Ben-Shlomo, M. Hu. Clinical predictors of screen-defined dementia in early Parkinson’s [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/clinical-predictors-of-screen-defined-dementia-in-early-parkinsons/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-predictors-of-screen-defined-dementia-in-early-parkinsons/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley